125 related articles for article (PubMed ID: 7713133)
1. Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
Bjerkehagen B; Fosså SD; Raabe N; Holm R; Nesland JM
Eur Urol; 1994; 26(4):334-9. PubMed ID: 7713133
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Berner A; Jacobsen AB; Fosså SD; Nesland JM
Histopathology; 1993 Apr; 22(4):327-33. PubMed ID: 8099896
[TBL] [Abstract][Full Text] [Related]
3. [p16, p53 and c-erbB-2 gene expression in bladder carcinoma].
Wang C; Liu X; Wang L; Chen D; Tan Z; Wang Z; Chen T
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):20-3. PubMed ID: 11866886
[TBL] [Abstract][Full Text] [Related]
4. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG
Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
Ioachim E; Charchanti A; Stavropoulos NE; Skopelitou A; Athanassiou ED; Agnantis NJ
Histol Histopathol; 2000 Jul; 15(3):721-7. PubMed ID: 10963116
[TBL] [Abstract][Full Text] [Related]
6. [The expression of p53 and c-erb-2 in transitional cell carcinoma of the kidney pelvis and ureter and its relation to tumor progression and survival].
Fontana LO; García García F; Arcas Martínez Salas I; García Ligero J; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Canteras Jordana M
Arch Esp Urol; 2002 Sep; 55(7):792-6. PubMed ID: 12380307
[TBL] [Abstract][Full Text] [Related]
7. Nuclear p53 overexpression in bladder, prostate, and renal carcinomas.
Sinik Z; Alkibay T; Ataoglu O; Biri H; Sözen S; Deniz N; Karaoglan U; Bozkirli I
Int J Urol; 1997 Nov; 4(6):546-51. PubMed ID: 9477181
[TBL] [Abstract][Full Text] [Related]
8. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
9. p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer.
Moch H; Sauter G; Moore D; Mihatsch MJ; Gudat F; Waldman F
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):329-34. PubMed ID: 7509541
[TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
[TBL] [Abstract][Full Text] [Related]
11. Immunodetection of androgen receptor in human urinary bladder cancer.
Zhuang YH; Bläuer M; Tammela T; Tuohimaa P
Histopathology; 1997 Jun; 30(6):556-62. PubMed ID: 9205860
[TBL] [Abstract][Full Text] [Related]
12. p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer.
Moch H; Sauter G; Mihatsch MJ; Gudat F; Epper R; Waldman FM
Hum Pathol; 1994 Dec; 25(12):1346-51. PubMed ID: 8001930
[TBL] [Abstract][Full Text] [Related]
13. Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer.
Lipponen PK
Pathobiology; 1993; 61(3-4):178-82. PubMed ID: 8105802
[TBL] [Abstract][Full Text] [Related]
14. Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices.
Ioachim E; Charchanti A; Stavropoulos N; Athanassiou E; Bafa M; Agnantis NJ
Anticancer Res; 2002; 22(6A):3383-8. PubMed ID: 12530091
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of the proliferating ability and malignant potential of transitional cell carcinoma in the human urinary bladder.
Yoshikawa H; Ikeuchi T; Kai Y
Int J Urol; 1996 Jan; 3(1 Suppl):S32-4. PubMed ID: 24304017
[TBL] [Abstract][Full Text] [Related]
16. [Expression of PCNA/cyclin, p53, C-erbB-2 versus histological grade in transitional cell carcinoma of urinary bladder].
Yoshikawa H; Ikeuchi T; Iguchi H; Onodera Y; Kai Y
Hinyokika Kiyo; 1995 Apr; 41(4):253-8. PubMed ID: 7785554
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 and mdm2 and their significance in recurrence of superficial bladder cancer.
Tuna B; Yörükoğlu K; Tüzel E; Güray M; Mungan U; Kirkali Z
Pathol Res Pract; 2003; 199(5):323-8. PubMed ID: 12908522
[TBL] [Abstract][Full Text] [Related]
18. [Overexpression of c-erbB-2 and p53 oncoprotein in renal pelvic and ureteral carcinomas with reference to the expression of Ki-67 antigen as a proliferation marker].
Hashimoto H; Sue Y; Tokumitsu M; Saga Y; Yachiku S
Nihon Hinyokika Gakkai Zasshi; 1997 Jun; 88(6):605-11. PubMed ID: 9234617
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
Rasmuson T; Grankvist K; Roos G; Ljungberg B
Acta Oncol; 1999; 38(5):623-8. PubMed ID: 10427952
[TBL] [Abstract][Full Text] [Related]
20. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis.
García-Tello A; Angulo JC; Andrés G; Ramón de Fata F; Sánchez-Chapado M; López JI
Actas Urol Esp; 2014 Oct; 38(8):506-14. PubMed ID: 24702909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
